Correlating the OA Knee Microenvironment to Outcomes After Regenexx-SD Treatment: A Multi-Site Study
A Prospective Analysis Correlating the Osteoarthritic Knee Microenvironment to Clinical Outcome After Treatment With Regenexx® SD Treatment: A Multi-Site Study
Sponsor: Regenexx, LLC
Terminated
sponsor discontinued study-impacted by COVID
Other terminated trials from Regenexx, LLC
- Lumbar Radiculopathy · Phase NA · Nov 2025
- Low Back Pain · Phase NA · Jun 2022
- Covid19 · Phase NA · Jun 2021
- Osteoarthritis, Knee · Mar 2018
- Disc Degeneration · Phase NA · May 2016
More terminations from Regenexx, LLC
Listed as NCT03898388, this NA trial focuses on Knee Osteoarthritis and remains terminated or withdrawn. Sponsored by Regenexx, LLC, it has been updated 8 times since 2019, reflecting limited change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.
Status Flow
Change History
8 versions recorded-
Sep 2024 — Present [monthly]
Terminated NA
-
Jul 2024 — Sep 2024 [monthly]
Terminated NA
-
Oct 2023 — Jul 2024 [monthly]
Terminated NA
Status: Enrolling By Invitation → Terminated
-
Feb 2022 — Oct 2023 [monthly]
Enrolling By Invitation NA
-
Jan 2021 — Feb 2022 [monthly]
Enrolling By Invitation NA
▶ Show 3 earlier versions
-
Aug 2020 — Jan 2021 [monthly]
Enrolling By Invitation NA
-
Aug 2019 — Aug 2020 [monthly]
Enrolling By Invitation NA
-
May 2019 — Aug 2019 [monthly]
Enrolling By Invitation NA
First recorded
Mar 2019
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- Regenexx, LLC
For direct contact, visit the study record on ClinicalTrials.gov .